Suppr超能文献

蛋白激酶C介导大鼠实验性结肠炎。

Protein kinase C mediates experimental colitis in the rat.

作者信息

Brown J F, Chang Q, Soper B D, Tepperman B L

机构信息

Department of Physiology, Faculty of Medicine, University of Western Ontario, London, Ontario, Canada N6A 5C1.

出版信息

Am J Physiol. 1999 Mar;276(3):G583-90. doi: 10.1152/ajpgi.1999.276.3.G583.

Abstract

Protein kinase C (PKC) plays an important role in the cell signal transduction of many physiological processes. In contrast to these physiological responses, increases in PKC activity have also been associated with inflammatory disease states, including ulcerative colitis. The objective of this study was to examine the role of PKC as a causative mediator in initiation of experimentally induced colitis in the rat. Colitis was induced in rats by intrarectal (0.6 ml) instillation of 2,4,6-trinitrobenzenesulfonic acid (TNBS; 75 mg/kg in 50% ethanol) or the PKC activator phorbol 12-myristate 13-acetate (PMA; 1.5-3.0 mg/kg in 20% ethanol). Gross and histological mucosal damage, mucosal neutrophil infiltration, mucosal PKC activity, and PKC protein content for PKC isoforms alpha, beta, delta, and epsilon were assessed 2 h to 14 days after an inflammatory challenge. Both PKC activity and mucosal injury increased significantly within 4 h of TNBS treatment. PKC activity was maximal at 7 days and declined at 14 days, whereas mucosal damage became maximal at 1 day and declined after 7 days. In contrast, neutrophil infiltration as assessed by myeloperoxidase activity only increased 12 h after TNBS treatment, became maximal 1 day after TNBS administration, and declined thereafter. PKCbeta, -delta, and -epsilon were increased in response to TNBS, whereas PKCalpha protein content was decreased. The PKC antagonists staurosporine and GF-109203X (25 ng/kg iv) reduced TNBS-induced changes in mucosal PKC activity and the degree of mucosal damage. In contrast, neutropenia induced by antineutrophil serum treatment did not significantly affect the degree of injury or mucosal PKC activity. Furthermore, activation of mucosal PKC activity with PMA also induced mucosal damage, which was also inhibited by pretreatment with a PKC antagonist. In conclusion, these results suggest that increases in PKC activity play a causative role in TNBS-induced colitis. The PKC-mediated response to TNBS does not appear to involve neutrophil infiltration.

摘要

蛋白激酶C(PKC)在许多生理过程的细胞信号转导中发挥着重要作用。与这些生理反应相反,PKC活性的增加也与包括溃疡性结肠炎在内的炎症性疾病状态有关。本研究的目的是探讨PKC作为大鼠实验性诱导结肠炎起始过程中的致病介质的作用。通过直肠内(0.6 ml)注入2,4,6-三硝基苯磺酸(TNBS;75 mg/kg溶于50%乙醇)或PKC激活剂佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA;1.5 - 3.0 mg/kg溶于20%乙醇)诱导大鼠发生结肠炎。在炎症刺激后2小时至14天,评估大体和组织学黏膜损伤、黏膜中性粒细胞浸润、黏膜PKC活性以及PKC同工型α、β、δ和ε的PKC蛋白含量。TNBS处理后4小时内,PKC活性和黏膜损伤均显著增加。PKC活性在7天时达到最大值,14天时下降,而黏膜损伤在1天时达到最大值,7天后下降。相比之下,通过髓过氧化物酶活性评估的中性粒细胞浸润仅在TNBS处理后12小时增加,在TNBS给药后1天达到最大值,此后下降。TNBS刺激后PKCβ、δ和ε增加,而PKCα蛋白含量降低。PKC拮抗剂星形孢菌素和GF - 109203X(25 ng/kg静脉注射)可降低TNBS诱导的黏膜PKC活性变化和黏膜损伤程度。相比之下,抗中性粒细胞血清处理诱导的中性粒细胞减少并未显著影响损伤程度或黏膜PKC活性。此外,用PMA激活黏膜PKC活性也会诱导黏膜损伤,PKC拮抗剂预处理也可抑制这种损伤。总之,这些结果表明PKC活性增加在TNBS诱导的结肠炎中起致病作用。PKC介导的对TNBS的反应似乎不涉及中性粒细胞浸润。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验